COVID-19 Variant Supplement – SARS-CoV2 therapeutic discovery through genetic screens and repurposing drugs that target essential virus-host interactions. Wilson, Joyce A | University of Saskatchewan | Operating Grant | $50,000 CIHR Saskatchewan 2021 Read More